Navigation Links
Let there be light: Teaching magnets to do more than just stick around
Date:8/20/2009

carbon-based materials using techniques not typically practical for magnetic semiconductors.

"We've brought these spin effects into a processable form," he said. "I think both of these papers are converging on the same applications. We're exploring how to manipulate spins in these nanostructures and perhaps opening the door for some exciting new technologies."


'/>"/>

Contact: Vince Stricherz
vinces@u.washington.edu
206-543-2580
University of Washington
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology technology :

1. NPL research shows there could be no end in sight for Moore’s Law
2. Tethered molecules act as light-driven reversible nanoswitches
3. Diverse Coalition of Purchasers Respond to BIO CEO Fly-In: There is Another Side to The Story
4. Tethered to chip, energy supply that drives sperm could power nanobot
5. Let there be light: new magnet design continues magnet labs tradition of innovation
6. Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition
7. Call for Applications: The Amgen Award for Science Teaching Excellence
8. Teaching old drugs new tricks
9. Nanomagnets guide stem cells to damaged tissue
10. Sophisticated nano-structures assembled with magnets
11. New kind of MRI enables study of magnets for computer memory

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...SEATTLE, Nov. 19 Omeros ...ited financial results for the third quarter ended...ptember 30, 2009, Omeros reported a net loss of $3...et loss of $7.4 million, or $2.54 per share, for t...September 30, 2009, the Company reported a net los...
(Date:11/19/2009)..., ,, BETHESDA, Md., Nov. 19 /PRNewswire-Fir...an innovator in biotechnology for diabetes therapy...lting services to food, supplement, biotechnology ...losed the previously reported $6.3 million registe... 2,760,870 shares of its common stock and warrants...
(Date:11/19/2009)...BETHESDA, Md., Nov. 19 S... in biotechnology for diabetes therapy, and a prov...es to food, supplement, biotechnology and pharmace...uesday,s Annual Meeting of Shareholders. ,, At ...(Nasdaq: SPEX ) elected the following members to ...
(Date:11/19/2009)..., MUNSTER, Germany, November 19 /PRNewswire/ ...filed on November 16th, 2009 Flibanserin in the,in...nesia in Parkinson,s,disease for orphan drug statu...EMEA). Levodopa-induced dyskinesia is a complicati...,s and a serious burden to some of those,affected,...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
... Time -, SAN FRANCISCO, Nov. 10 Medivation, Inc....progress and financial,results for the quarter end...ented another quarter of significant,achievement a... partnering,agreement with Pfizer for Dimebon. Thi...d-class partner capable of maximizing global,comme...
... Discuss the Data and Ongoing ...Nov. 10 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ...1 clinical trial, one of Sangamo,s three Phase 2 c...am to develop SB-509 for diabetic,neuropathy (DN)....f the,drug is well tolerated in subjects with mild...
...es of Non-Core Product Lines -, HOPKINTON, Mass.,...LP ) today reported third quarter financial,result...divestitures: the,sale of its AutoTrace(R) product...he sale of its Pharmaceutical Development and Qual...on for $15.8 million. Revenues for the,quarter wer...
Other Biology Technology:Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 2Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 3Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 4Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 5Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 6Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 7Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 8Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 2Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 3Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 4Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 5Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 6Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 2Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 3Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 4Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 5Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 6Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 7Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 8Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 9Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 10Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 11
(Date:11/23/2009)... strong evidence that the "synergistic" effect of ...d pollution and indoor endotoxin causes more harm ... alone. , Environmental health scientists at t...ne have shown that children exposed to both high l...toxin during early life are six times more likely ...
(Date:11/23/2009)...-associated strain of the deadly superbug MRSAan i... antibioticsposes a far greater health threat than...tals, according to a study in the December issue o...eat is easily picked up in fitness centers, school...verall burden of MRSA within hospitals, the report...
(Date:11/23/2009)...23, 2009 Applied mathematicians dissected the mor... a characteristic long leaf with a saddle-like arc...dges. The simple cause of the lily,s fan-like shap...differential growthwas revealed by using an equall...aiyi Liang, a postdoctoral student at Harvard,s Sc...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2New study finds MRSA on the rise in hospital outpatients 2The cause behind the characteristic shape of a long leaf revealed 2National Trauma Institute Announces 24600 000 in Funding for Trauma Research 59673 1National Trauma Institute Announces 24600 000 in Funding for Trauma Research 59673 2Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 1Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 2Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 3Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 4Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 5Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 6Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 7Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 8Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 9U M to Host Two Part Tweet Chat on H1N1 Swine Flu Oct 22 59665 1
...h, and still the University of Wisconsin-Madison S...requests. Since 1998, the school,s oncology depar...r dogs diagnosed with melanoma. Though it is sti...over the nation have wanted to participate in the ...heir pet. , After promising results from work done...
...we carry this activity out through the placenta an...velopment, the lungs of the foetus are filled with... activates this respiration surface. But the main ...ungs are not well formed. Moreover, they often lac...pids that avoids the lungs folding in on themselve...
...billion-base human genome play a vital role in a b...chers from the Wellcome Trust Sanger Institute and...r Medical Research, together with international co...ps of differences implicated in disease as well as... , The Major Histocompatibility Complex (MHC) con...
Other Biology News:Canine cancer vaccine program shows early promise 2Liquid ventilation 2Researchers map of genetic variations implicated in disease 2Researchers map of genetic variations implicated in disease 3
...ein Phosphatase-2A (PPase-2A) is a serine/threonin... It is isolated as the heterodimer of 60kDa (A) an...phorylate the a-subunit of phosphorylase kinase. W...oad substrate specificity and may play a regulator...
...oskan is a high performance spectral scanning mult.... With the advanced SkanIt Software it offers supe...y assay development. Varioskan provides unlimited ...ime-resolved fluorescence and photometric assays a...
...ctively condenses and traps a wide variety of solv... pump oil. Easy-to-use glass condensation flask (G...self contained jar for easy draining. Rapid coolin...4 o C temperature traps high volatile solvents ...
Immulon 2HB from Thermo Scientific
Biology Products: